Hepatic artery embolization for inoperable hepatocellular carcinoma; prognosis and risk factors.

MLA

Takayasu, K., et al. “Hepatic Artery Embolization for Inoperable Hepatocellular Carcinoma; Prognosis and Risk Factors.” Cancer Chemotherapy and Pharmacology, vol. 23 Suppl, 1989, pp. S123–25. EBSCOhost, https://doi.org/10.1007/BF00647257.

APA

Takayasu, K., Suzuki, M., Uesaka, K., Muramatsu, Y., Moriyama, N., Yoshida, T., Yoshino, M., Okazaki, N., & Hasegawa, H. (1989). Hepatic artery embolization for inoperable hepatocellular carcinoma; prognosis and risk factors. Cancer Chemotherapy and Pharmacology, 23 Suppl, S123–S125. https://doi.org/10.1007/BF00647257

Chicago

Takayasu, K, M Suzuki, K Uesaka, Y Muramatsu, N Moriyama, T Yoshida, M Yoshino, N Okazaki, and H Hasegawa. 1989. “Hepatic Artery Embolization for Inoperable Hepatocellular Carcinoma; Prognosis and Risk Factors.” Cancer Chemotherapy and Pharmacology 23 Suppl: S123–25. doi:10.1007/BF00647257.